Amgen

At Amgen, every product we make carries the potential to transform lives. Today, on #ManufacturingDay, we celebrate the incredible impact of modern manufacturing and the innovation driving our mission to serve patients worldwide. Here’s a look at Amgen’s Operations: 1️⃣ We operate 8 cutting-edge manufacturing sites around the globe, 5 in the United States (CA, NC, OH, PR, RI) along with Singapore, Ireland, and the Netherlands. 2️⃣ Our global network of dedicated professionals ensures our products are produced, assembled, packaged, and labeled for over 100 markets, that make a difference in the lives of patients and their families around the world. 3️⃣ Quality is at the core of everything we do. Each site undergoes rigorous checks of its facilities, utilities, raw materials, and products. We also conduct deep analyses of our performance to drive continuous improvement and maintain the highest standards. 4️⃣ In 2023, Amgen introduced the Sustainability Maturity Matrix—a powerful framework guiding our sites to reduce energy and water use and divert waste from landfills, underscoring our commitment to both patient care and environmental stewardship. We honor the extraordinary efforts of our teams and the advanced technologies that allow us to continually raise the bar in quality, safety, compliance and sustainability. #MFGDay #MFGDay24

As we wrap up #NationalCholesterolEducationMonth, Amgen’s commitment to prioritizing heart health only grows stronger! Our team accepted the #CheckLDL challenge to better understand their risk for attack and stroke — for themselves, their families, friends, and the patients we serve. Let’s keep up the momentum and prioritize getting your LDL-C level checked regularly, especially if you have heart disease. Find more information, including how to get a free LDL-C test, at: 🔗 https://amgen.ly/checkldl

In recognition of National Disability Employment Awareness Month, Erik Schrage, Director, Global Clinical Supply Chain and lead of our Ability Bettered Through Leadership and Education employee resource group in Breda, shares his experience as a caregiver to his son living with a disability and his commitment to fostering an inclusive workplace where every individual feels they can thrive and make meaningful contributions. #NDEAM2024 #NDEAM

Actress, producer, entrepreneur–La La Anthony does it all. But behind the scenes, plaque psoriasis has been a constant challenge. Now, she's opening up about how the disease impacts her life, in both personal and professional moments. Her message? Don’t be afraid to talk to your doctor. Let her story inspire you to start the conversation: https://amgen.ly/3TQpZvJ #AmgenSponsored

Amgen is driven by a bold ambition to cut heart attacks and strokes in half by 2030. A key part of this mission is tackling high LDL ("bad") cholesterol, a silent risk factor for #ASCVD (atherosclerotic cardiovascular disease). Early detection and proactive management are key to reducing your risk. This #WorldHeartDay, take action to lower your risk. Talk to your doctor and visit 🔗 www.attackheartdisease.com to learn how you can get information on a free LDL-C test, especially if you’ve had a heart attack or stroke. #CheckLDL

With Amgen job alerts, you’ll get updates on the latest career opportunities that match your experience! Sign up today and start seeing what’s available: https://bit.ly/3TM6QuL

Innovation is unfolding at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Toronto! Millions of women around the globe are affected by osteoporosis, yet many remain undiagnosed and untreated–this urgent care gap is what drives our collaboration with healthcare leaders worldwide to confront this silent disease head on. At Amgen, we’re advocating for post-menopausal women to get a bone scan, know their risk, and understand treatment options available.  #ASBMR2024 

Building an amazing culture has always been a top priority. That’s why we’re proud to be recognized as the #1 best workplace in Portugal in the 201-500 employees category. Ready to experience it for yourself? Learn more and apply: https://bit.ly/47NKQp5

Today, Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Amgen’s IGF-1R inhibitor for the treatment of active Thyroid Eye Disease (TED). We are proud to be able to provide the first and only nonsteroidal, nonsurgical treatment option for those living with TED in Japan. 🔗 https://amgen.ly/3ZCIRlt

We’re proud to support a new City Cancer Challenge initiative launched today at the Clinton Global Initiative Annual Meeting #CGI2024. Spurred by The Lancet Commission on Women, power cancer, it centers #GenderEquity local needs of women living in Low- and Middle-Income Countries (#LMICs) to advance #CancerCare. 🔗 Learn more about this news: https://amgen.ly/3zvi8wu